{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:24:02Z","timestamp":1762100642981},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.2515\/therapie:2006020","type":"journal-article","created":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T10:59:19Z","timestamp":1176980359000},"page":"93-99","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence and Costs of Parkinsonian Syndromes Associated with Orthostatic Hypotension"],"prefix":"10.1016","volume":"61","author":[{"given":"Karine","family":"Desboeuf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Riche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Fradin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Senard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2006020_bb0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/archinte.1992.00400170130024","article-title":"Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group","volume":"152","author":"Ensrud","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.2515\/therapie:2006020_bb0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.HYP.19.6.508","article-title":"Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group","volume":"19","author":"Rutan","year":"1992","journal-title":"Hypertension"},{"key":"10.2515\/therapie:2006020_bb0020","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinte.1995.00430090067008","article-title":"Prevalence, predisposing factors, and prognostic importance of postural hypotension","volume":"155","author":"Raiha","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.2515\/therapie:2006020_bb0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000106629","article-title":"Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women","volume":"8","author":"Elmstahl","year":"1997","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.2515\/therapie:2006020_bb0030","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.STR.31.10.2307","article-title":"Orthostatic hypotension as a risk factor for stroke. The Atherosclerosis Risk in Communities (ARIC) study, 1987-1996","volume":"31","author":"Eigenbrodt","year":"2000","journal-title":"Stroke"},{"key":"10.2515\/therapie:2006020_bb0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0895-7061(99)00257-5","article-title":"Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities Study","volume":"13","author":"Rose","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.2515\/therapie:2006020_bb0040","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.CIR.98.21.2290","article-title":"Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program","volume":"98","author":"Masaki","year":"1998","journal-title":"Circulation"},{"key":"10.2515\/therapie:2006020_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: a review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Mov Disord"},{"key":"10.2515\/therapie:2006020_bb0050","first-page":"463","article-title":"Autonomic nervous system disturbances in Parkinson\u2019s disease","volume":"53","author":"Korczyn","year":"1990","journal-title":"Adv Neurol"},{"key":"10.2515\/therapie:2006020_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jnnp.63.5.584","article-title":"Prevalence of orthostatic hypotension in Parkinson\u2019s disease","volume":"63","author":"Senard","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.2515\/therapie:2006020_bb0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00002512-200118070-00003","article-title":"Orthostatic hypotension in patients with Parkinson\u2019s disease: pathophysiology and management","volume":"18","author":"Senard","year":"2001","journal-title":"Drugs Aging"},{"key":"10.2515\/therapie:2006020_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00002018-199717020-00003","article-title":"Drug-induced orthostatic hypotension in the elderly: avoiding its onset","volume":"17","author":"Verhaeverbeke","year":"1997","journal-title":"Drug Safety"},{"key":"10.2515\/therapie:2006020_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00019053-199916010-00006","article-title":"Cost of illness and disease severity in a cohort of French patients with Parkinson\u2019s disease","volume":"16","author":"LePen","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.2515\/therapie:2006020_bb0075","first-page":"113","article-title":"on behalf of the Medipath group. Prevalence de la maladie de Parkinson et co\u00fbt pour l\u2019Assurance Maladie en 2000 en France m\u00e9tropolitaine","volume":"36","author":"Lajugie","year":"2005","journal-title":"Rev Med Ass Maladie"},{"key":"10.2515\/therapie:2006020_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00019053-199814030-00006","article-title":"The economic impact of Parkinson\u2019s disease. An estimation based on a 3-month prospective analysis","volume":"14","author":"Dodel","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"10.2515\/therapie:2006020_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mds.870130209","article-title":"Costs of drug treatment in Parkinson\u2019s disease","volume":"13","author":"Dodel","year":"1998","journal-title":"Mov Disord"},{"key":"10.2515\/therapie:2006020_bb0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mds.870130306","article-title":"The health burdens of Parkinson\u2019s disease","volume":"13","author":"Chrischilles","year":"1998","journal-title":"Mov Disord"},{"key":"10.2515\/therapie:2006020_bb0095","unstructured":"Anonymous Anatomical Therapeutic Chemical (ATC) classification index including defined daily doses (DDDs) for plain substances WHO Collaborating Centre for Drug Statistic Methodology, Norwegian Institute of Public Health. The ATC\/DDD system Available on URL http:\/\/www.whocc.no"},{"key":"10.2515\/therapie:2006020_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0404.1994.tb02689.x","article-title":"Prevalence of Parkinson\u2019s disease in the elderly: a population study in Gironde, France","volume":"90","author":"Tison","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.2515\/therapie:2006020_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","article-title":"Prevalence of parkinsonism and Parkinson\u2019s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson\u2019s disease","volume":"62","author":"de Rijk","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 5","key":"10.2515\/therapie:2006020_bb0110","first-page":"S21","article-title":"Prevalence of Parkinson\u2019s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"de Rijk","year":"2000","journal-title":"Neurology"},{"key":"10.2515\/therapie:2006020_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1023\/A:1011807919632","article-title":"Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson\u2019s disease","volume":"23","author":"Van de Vijver","year":"2001","journal-title":"Pharmacy World & Science"},{"key":"10.2515\/therapie:2006020_bb0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pds.624","article-title":"Estimation of incidence and prevalence of Parkinson\u2019s disease in elderly using pharmacy records","volume":"10","author":"Van de Vijver","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.2515\/therapie:2006020_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0404.1994.tb02662.x","article-title":"Prevalence of anti-parkinson drugs\u2019 use in Ferrara, northern Italy, 1988","volume":"89","author":"Govoni","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.2515\/therapie:2006020_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.65.3.285","article-title":"Treatment of postural hypotension","volume":"65","author":"Mathias","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.2515\/therapie:2006020_bb0135","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.2515\/therapie:2006020_bb0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(00)82050-4","article-title":"Prevalence of multiple system atrophy","volume":"355","author":"Tison","year":"2000","journal-title":"Lancet"},{"key":"10.2515\/therapie:2006020_bb0145","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.67.5.620","article-title":"Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study","volume":"67","author":"Wennings","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.2515\/therapie:2006020_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02281114","article-title":"Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variability","volume":"10","author":"Brefel-Courbon","year":"2000","journal-title":"Clin Auton Res"},{"key":"10.2515\/therapie:2006020_bb0155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(03)00555-6","article-title":"Dysautonomia in Parkinson\u2019s disease: neurocardiological abnormalities","volume":"2","author":"Goldstein","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.2515\/therapie:2006020_bb0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0404.1990.tb01568.x","article-title":"Cardiovascular reflexes in Parkinson\u2019s diesase: long term effects of levodopa treatment on de novo patients","volume":"81","author":"Camerlingo","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"10.2515\/therapie:2006020_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(94)90218-6","article-title":"Tolerance to peripheral, but not central, effects of ropinirole, a selective dopamine D2-like receptor agonist","volume":"265","author":"Parker","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie:2006020_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2125.1980.tb04795.x","article-title":"Cross tolerance between two dopaminergic ergot derivatives, bromocriptine and lergotrile","volume":"9","author":"Teychenne","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie:2006020_bb0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1476-5381.1996.tb15260.x","article-title":"A study of tolerance to apomorphine","volume":"117","author":"Montastruc","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.2515\/therapie:2006020_bb0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/jnnp.56.10.1090","article-title":"Autonomic nervous system dysfunction in Parkinson\u2019s disease: relationship with age, medication, duration and severity","volume":"56","author":"van Dijk","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.2515\/therapie:2006020_bb0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","article-title":"Neurogenic orthostatic hypotension: a double blind placebo-controlled study with midodrine","volume":"95","author":"Jankovic","year":"1993","journal-title":"Am J Med"},{"issue":"13","key":"10.2515\/therapie:2006020_bb0190","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension","volume":"277","author":"Low","year":"1997","journal-title":"JAMA"},{"key":"10.2515\/therapie:2006020_bb0195","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(03)00555-6","article-title":"Dysautonomia in Parkinson\u2019s disease: neurocardiological abnormalities","volume":"2","author":"Goldstein","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.2515\/therapie:2006020_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00002826-199302000-00008","article-title":"Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson\u2019s disease or multiple system atrophy","volume":"16","author":"Senard","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.2515\/therapie:2006020_bb0205","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/WNL.46.5.1470","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy","volume":"46","author":"The Consensus Committee of the American Autonomic Society and the American Academy of Neurology","year":"1996","journal-title":"Neurology"},{"key":"10.2515\/therapie:2006020_bb0210","first-page":"153","article-title":"UPDRS program members. Unified Parkinson\u2019s disease rating scale","volume":"vol 2","author":"Fahn","year":"1987"},{"key":"10.2515\/therapie:2006020_bb0215","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The unified Parkinson\u2019s disease rating scale (UPDRS): status and recommendations","volume":"18","author":"Movement disorder Society Task Force on rating scales for Parkinson\u2019s disease","year":"2003","journal-title":"Mov Disord"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T02:59:11Z","timestamp":1554260351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716303717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0040595716303717"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2006020","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}